RxDoctor Payments Data

Juan Vicenty Padilla, MD

Neurological Surgery · Caguas, PRNPI 1942564729

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $3,212 of the $3,870 with a category attached, or 83.0%. Medtronic accounts for 74.9% of it on its own, with 6 other manufacturers making up the rest.

$3,870in general payments, 2019–2025

Across 70 payments — averaging $55.28 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Medtronic$3K
  • Penumbra, Inc.$528
  • Johnson And Johnson International$263
  • Medexus Pharma, Inc.$122
  • Johnson & Johnson$24
  • Cordis US CORP.$18
  • plus $15 from 1 others

What the payments were for

  • Travel & lodging$65817%
  • Food & beverage$3,21283%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Medtronic(2 entities)55$2,900
Penumbra, Inc.6$528
Johnson And Johnson International5$263
Medexus Pharma, Inc.1$122
Johnson & Johnson1$24
Cordis US CORP.1$18
Chiesi USA, Inc.1$15

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$3,870 in reported general payments places this provider in the 60th percentile of 39 neurological surgery providers in Puerto Rico.

See all neurological surgery providers in Puerto Rico

Medicare billing

Part B allowed, 2024
$15,134
Medicare patients
24
Services billed
46

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Levetiracetam13$411
ClopidogrelClopidogrel Bisulfate33$265
Gabapentin13$125

Paid to pharmacies, not to this prescriber.

Other neurological surgery in Caguas

See the full list for Puerto Rico

Where these figures come from

Is this you, or does something look wrong? →